Greater Boston
Biomedical engineer and medtech entrepreneur focused on translating engineering innovation into clinically impactful healthcare technologies.
Co-lead the Looking Beyond the Brand: Bringing Generics and Biosimilars Into the Public Eye project, overseeing a team of junior fellows conducting original policy research on generic and biosimilar market dynamics, patient access, and public awareness. Review and edit fellow-authored articles for analytical rigor and policy relevance, while providing mentorship on research methodology, regulatory frameworks, and health policy communication. Shape the strategic direction of the project's research agenda at the intersection of pharmaceutical competition, FDA regulatory policy, and health equity.
Conducted health policy research through a nationally competitive fellowship program focused on pharmaceutical access and patient advocacy. Led an independent analysis of eculizumab biosimilar competition and its implications for rare disease patient access, producing a published policy brief drawing on FDA regulatory data, payer economics, and comparative drug pricing frameworks. Developed expertise in health policy research methodology, stakeholder landscape mapping, and evidence-based advocacy across the pharmaceutical and payer ecosystem.
Developing and optimizing tools for optical electrophysiology in engineered 3D neural tissue models. Work includes viral vector delivery, live confocal imaging, immunohistochemistry, custom hardware design and electrical characterization, and quantitative signal analysis. Demonstrated stimulus-evoked membrane potential recordings at single-cell resolution in a 3D cortical tissue preparation.